Article

Individualized screening for chaperone activity in Gaucher disease using multiple patient derived primary cell lines

2018-02-01

Abstract excerpt

No abstract is available from the source.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9133da3d-523b-5869-929a-da176963c8a4
DOI: 10.1016/j.ymgme.2017.12.170

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Individualized screening for chaperone activity in Gaucher disease using multiple patient derived primary cell linesDOI 10.1016/j.ymgme.2017.12.170Read

Gaucher disease phenotypes outflanked?Semantic proximity Read

Phenotype, diagnosis, and treatment of Gaucher's disease.Semantic proximity Read

Gaucher disease types 1 and 3: Phenotypic characterization of large populations from the ICGG Gaucher Registry.Semantic proximity Read

Cell-based screening of active-site specific chaperone for the treatment of Fabry disease.Semantic proximity Read

Chaperone therapy for Krabbe disease: potential for late-onset GALC mutationsSemantic proximity Read

Gaucher disease: a prototype for molecular medicine.Semantic proximity Read

Progress and potential of non-inhibitory small molecule chaperones for the treatment of Gaucher disease and its implications for Parkinson disease.Semantic proximity Read

N-Octyl-β-valienamine up-regulates activity of F213I mutant β-glucosidase in cultured cells: a potential chemical chaperone therapy for Gaucher diseaseSemantic proximity Read

Gaucher disease phenotype.Semantic proximity Read

Gaucher disease, a paradigm for single gene defects.Semantic proximity Read

Gaucher disease: multiple lessons from a single gene disorderSemantic proximity Read

Genotype/phenotype correlations in Gaucher's disease.Semantic proximity Read